ACETAMINOPHEN 500MG

ACETAMINOPHEN 500MG was reported 260722 times

ACETAMINOPHEN 500MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PYROGLUTAMIC ACIDOSIS 308 0.7758
1 VAGINAL FLATULENCE 225 0.7426
2 APPENDICOLITH 285 0.7364
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 420 0.6287
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 4464 0.6224
5 RHEUMATIC FEVER 2759 0.6183
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 1220 0.6091
7 DUODENAL ULCER PERFORATION 4510 0.6059
8 SWOLLEN JOINT COUNT INCREASED 1920 0.6015
9 C-REACTIVE PROTEIN 543 0.5858
10 LUPUS VULGARIS 716 0.5683
11 EXPOSURE TO TOXIC AGENT 1696 0.5297
12 FACET JOINT SYNDROME 1714 0.5259
13 BLOOD PRESSURE DIASTOLIC ABNORMAL 1293 0.5079
14 BLOOD PRESSURE SYSTOLIC ABNORMAL 1195 0.4830
15 RHEUMATOID FACTOR POSITIVE 2792 0.4829
16 MUSCLE INJURY 3818 0.4603
17 HELICOBACTER INFECTION 4573 0.4445
18 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 2808 0.4319
19 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 892 0.4301
20 FOLLICULITIS 4350 0.4144
21 PEMPHIGUS 5073 0.4054
22 X-RAY ABNORMAL 716 0.4000
23 HAND DEFORMITY 5206 0.3965
24 DISLOCATION OF VERTEBRA 883 0.3868
25 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 214 0.3815
26 ANALGESIC DRUG LEVEL INCREASED 595 0.3705
27 ANION GAP 214 0.3375
28 PERIPHERAL VENOUS DISEASE 1305 0.3192
29 SYNOVITIS 5668 0.3140
30 RETINITIS 539 0.3117
31 PERICARDITIS 5160 0.3068
32 C-REACTIVE PROTEIN ABNORMAL 1880 0.2928
33 MULTIPLE DRUG THERAPY 211 0.2798
34 SERONEGATIVE ARTHRITIS 278 0.2426
35 AMAUROSIS FUGAX 252 0.2340
36 SEDATION COMPLICATION 595 0.2330
37 GLOSSODYNIA 5100 0.2276
38 INFUSION SITE DISCHARGE 391 0.2228
39 PORPHYRIA ACUTE 305 0.2125
40 ACUTE HEPATIC FAILURE 2849 0.2083
41 IRRITABLE BOWEL SYNDROME 4367 0.2035
42 BREAST CANCER STAGE III 1287 0.1985
43 LIP DRY 1741 0.1915
44 DRUG TOLERANCE DECREASED 530 0.1885
45 WOUND 5233 0.1870
46 BURSITIS 2266 0.1866
47 BONE EROSION 657 0.1856
48 PHARYNGEAL PARAESTHESIA 292 0.1839
49 ONYCHOMADESIS 760 0.1809
50 HYPERCHOLESTEROLAEMIA 1729 0.1789
51 BLOOD PRESSURE DIASTOLIC DECREASED 1308 0.1770
52 JOINT RANGE OF MOTION DECREASED 2325 0.1732
53 INFUSION RELATED REACTION 11392 0.1717
54 POISONING DELIBERATE 1614 0.1701
55 GRIP STRENGTH DECREASED 1496 0.1698
56 WOUND INFECTION 1854 0.1691
57 INFUSION SITE PRURITUS 525 0.1662
58 CONTRAINDICATED PRODUCT ADMINISTERED 4930 0.1627
59 HEPATIC CYTOLYSIS 2066 0.1619
60 FEMALE GENITAL TRACT FISTULA 273 0.1597
61 ONYCHOMYCOSIS 696 0.1585
62 SYSTEMIC LUPUS ERYTHEMATOSUS 5590 0.1573
63 INFUSION SITE BRUISING 339 0.1568
64 LIVER INJURY 3802 0.1547
65 LIVE BIRTH 1243 0.1484
66 EAR PRURITUS 519 0.1479
67 SUSPECTED SUICIDE 693 0.1477
68 BLOOD PRESSURE DIASTOLIC INCREASED 677 0.1465
69 CREATININE RENAL CLEARANCE DECREASED 581 0.1450
70 BLOOD PRESSURE FLUCTUATION 3428 0.1427
71 IMPAIRED HEALING 4664 0.1419
72 TEMPERATURE REGULATION DISORDER 316 0.1417
73 INFUSION SITE HAEMORRHAGE 465 0.1412
74 BLOOD PRESSURE SYSTOLIC INCREASED 2705 0.1386
75 BLEPHAROSPASM 870 0.1380
76 AUTOIMMUNE DISORDER 1332 0.1365
77 FIBROMYALGIA 3273 0.1345
78 HYPERPHOSPHATAEMIA 287 0.1334
79 SCHIZOAFFECTIVE DISORDER 234 0.1311
80 WHITE BLOOD CELLS URINE POSITIVE 245 0.1301
81 PHYSICAL DECONDITIONING 334 0.1297
82 FINGER DEFORMITY 624 0.1287
83 LOWER RESPIRATORY TRACT INFECTION 5849 0.1285
84 INFUSION SITE SWELLING 796 0.1264
85 INFUSION SITE REACTION 373 0.1247
86 HYPERPARATHYROIDISM SECONDARY 297 0.1184
87 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1287 0.1162
88 HEPATIC NECROSIS 429 0.1138
89 CLOSTRIDIUM TEST POSITIVE 248 0.1124
90 RADICULOPATHY 296 0.1122
91 CHRONIC SINUSITIS 419 0.1115
92 MATERNAL EXPOSURE TIMING UNSPECIFIED 416 0.1106
93 NEPHROGENIC ANAEMIA 509 0.1098
94 ARTHROPATHY 5996 0.1078
95 SCIATICA 1707 0.1070
96 BODY TEMPERATURE DECREASED 1041 0.1056
97 NAIL DISORDER 924 0.1055
98 MULTIPLE DRUG OVERDOSE 518 0.1043
99 BLOOD PHOSPHORUS INCREASED 283 0.1035
100 THERAPEUTIC PRODUCT EFFECT DECREASED 4627 0.1032
101 HEPATITIS FULMINANT 306 0.1030
102 TYPE 2 DIABETES MELLITUS 3470 0.1030
103 HEPATIC ENZYME INCREASED 6978 0.1023
104 PERSONALITY DISORDER 267 0.1018
105 COMPLETED SUICIDE 8484 0.1017
106 PROCTITIS 285 0.1016
107 PLEURITIC PAIN 277 0.1003
108 MIXED LIVER INJURY 300 0.0996
109 TOXICITY TO VARIOUS AGENTS 16808 0.0996
110 INTENTIONAL OVERDOSE 6393 0.0996
111 OBESITY 1586 0.0994
112 INFUSION SITE ERYTHEMA 838 0.0993
113 INFUSION SITE EXTRAVASATION 617 0.0990
114 POOR VENOUS ACCESS 1016 0.0981
115 INFUSION SITE PAIN 1265 0.0981
116 WALKING AID USER 647 0.0980
117 METHAEMOGLOBINAEMIA 226 0.0975
118 AUTISM SPECTRUM DISORDER 520 0.0944
119 BLISTER 5227 0.0930
120 METABOLIC ACIDOSIS 2966 0.0927
121 INCORRECT DRUG ADMINISTRATION RATE 383 0.0899
122 BRONCHIECTASIS 600 0.0890
123 MULTIPLE DRUG OVERDOSE INTENTIONAL 283 0.0879
124 COELIAC DISEASE 860 0.0876
125 PULMONARY FIBROSIS 1653 0.0861
126 DEVICE INFUSION ISSUE 212 0.0854
127 SUSPECTED OFF LABEL USE 385 0.0851
128 C-REACTIVE PROTEIN INCREASED 3100 0.0851
129 ALCOHOL POISONING 228 0.0850
130 SINUSITIS 8671 0.0845
131 LUNG OPACITY 222 0.0842
132 STOMATITIS 5092 0.0839
133 DRUG TOXICITY 1142 0.0838
134 IRON DEFICIENCY 374 0.0831
135 PRESCRIBED OVERDOSE 1598 0.0825
136 DISCOMFORT 5010 0.0820
137 INTENTIONAL PRODUCT USE ISSUE 7151 0.0815
138 MULTIPLE ALLERGIES 639 0.0814
139 EXOSTOSIS 743 0.0813
140 RHEUMATOID ARTHRITIS 9203 0.0810
141 JAUNDICE CHOLESTATIC 286 0.0809
142 CYTOKINE RELEASE SYNDROME 1603 0.0798
143 RED CELL DISTRIBUTION WIDTH INCREASED 332 0.0798
144 DRUG-INDUCED LIVER INJURY 2501 0.0796
145 PRODUCT LABEL CONFUSION 463 0.0794
146 HEPATITIS ACUTE 515 0.0792
147 BLOOD CHOLESTEROL INCREASED 3682 0.0789
148 BODY TEMPERATURE INCREASED 1608 0.0787
149 HEPATOTOXICITY 1742 0.0782
150 BLOOD CALCIUM DECREASED 874 0.0776
151 HYPOPNOEA 268 0.0771
152 HEART RATE DECREASED 2709 0.0771
153 SWELLING 7212 0.0770
154 PSORIATIC ARTHROPATHY 3108 0.0765
155 JOINT SWELLING 9242 0.0765
156 HIP ARTHROPLASTY 1172 0.0764
157 RESPIRATORY RATE INCREASED 673 0.0757
158 NIGHT SWEATS 2425 0.0752
159 DRUG INTOLERANCE 7243 0.0749
160 FOOD ALLERGY 578 0.0748
161 MUSCLE SPASTICITY 915 0.0744
162 BACK INJURY 803 0.0738
163 MONOCYTE COUNT INCREASED 266 0.0732
164 MACULAR DEGENERATION 874 0.0731
165 END STAGE RENAL DISEASE 1332 0.0730
166 LOWER LIMB FRACTURE 1403 0.0729
167 RALES 424 0.0729
168 JOINT DISLOCATION 765 0.0723
169 FOOT DEFORMITY 798 0.0719
170 APLASTIC ANAEMIA 374 0.0715
171 BLOOD CREATININE DECREASED 223 0.0711
172 OSTEOARTHRITIS 3004 0.0708
173 PUSTULAR PSORIASIS 243 0.0707
174 COAGULOPATHY 1161 0.0696
175 PNEUMONIA VIRAL 221 0.0693
176 EAR PAIN 1346 0.0692
177 CYTOLYTIC HEPATITIS 229 0.0689
178 URINARY TRACT DISORDER 310 0.0688
179 ILL-DEFINED DISORDER 4140 0.0681
180 GAIT INABILITY 2260 0.0676
181 OXYGEN SATURATION DECREASED 3792 0.0674
182 MOBILITY DECREASED 4835 0.0672
183 TOXIC EPIDERMAL NECROLYSIS 1019 0.0670
184 SPONDYLITIS 242 0.0665
185 HYPOMANIA 240 0.0652
186 HEPATIC ENCEPHALOPATHY 608 0.0651
187 LIVER FUNCTION TEST INCREASED 1396 0.0650
188 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 329 0.0649
189 INFLAMMATION 3349 0.0648
190 ORTHOSTATIC HYPOTENSION 1127 0.0647
191 AORTIC STENOSIS 225 0.0645
192 VASCULAR DEVICE INFECTION 293 0.0645
193 BREATH SOUNDS ABNORMAL 318 0.0644
194 LUPUS-LIKE SYNDROME 581 0.0640
195 EAR INFECTION 1673 0.0628
196 WHEEZING 3713 0.0626
197 ULCER HAEMORRHAGE 423 0.0624
198 SUICIDE ATTEMPT 3786 0.0624
199 CONGENITAL ANOMALY 483 0.0623
200 BLOOD PRESSURE SYSTOLIC DECREASED 280 0.0615
201 HYPERTRANSAMINASAEMIA 427 0.0613
202 MAJOR DEPRESSION 447 0.0611
203 SEASONAL ALLERGY 861 0.0608
204 CARDIAC MURMUR 526 0.0607
205 HYPOPHOSPHATAEMIA 447 0.0604
206 URINE ABNORMALITY 274 0.0602
207 MUSCULOSKELETAL STIFFNESS 5244 0.0598
208 GASTROINTESTINAL DISORDER 5347 0.0596
209 FOETAL DEATH 309 0.0595
210 WEIGHT FLUCTUATION 622 0.0594
211 RHINITIS 479 0.0593
212 DELIRIUM 2056 0.0592
213 RASH VESICULAR 286 0.0591
214 FEBRILE NEUTROPENIA 3921 0.0590
215 RESPIRATORY DEPRESSION 722 0.0588
216 ACIDOSIS 447 0.0584
217 DEPRESSED LEVEL OF CONSCIOUSNESS 2308 0.0583
218 UPPER RESPIRATORY TRACT INFECTION 2689 0.0581
219 KNEE ARTHROPLASTY 1223 0.0580
220 BLOOD URIC ACID INCREASED 333 0.0576
221 COVID-19 PNEUMONIA 680 0.0575
222 HAEMORRHAGIC STROKE 449 0.0574
223 DRUG LEVEL BELOW THERAPEUTIC 314 0.0569
224 HEPATITIS CHOLESTATIC 339 0.0562
225 HEPATIC FAILURE 1687 0.0559
226 POISONING 701 0.0557
227 HEPATITIS 1401 0.0547
228 GENERAL PHYSICAL HEALTH DETERIORATION 6333 0.0547
229 ATELECTASIS 528 0.0546
230 ATTENTION DEFICIT HYPERACTIVITY DISORDER 230 0.0546
231 IMMUNODEFICIENCY 814 0.0546
232 LUNG DISORDER 2638 0.0538
233 MATERNAL EXPOSURE DURING PREGNANCY 4745 0.0532
234 DRUG USE DISORDER 447 0.0531
235 OEDEMA 2879 0.0530
236 SEDATION 1388 0.0529
237 RESPIRATORY TRACT INFECTION 1380 0.0529
238 BRAIN OEDEMA 669 0.0529
239 ANAL FISSURE 282 0.0525
240 CHOLESTASIS 1008 0.0524
241 NORMAL NEWBORN 285 0.0524
242 INJURY 3661 0.0520
243 LYMPHOCYTE COUNT DECREASED 920 0.0520
244 PRESCRIBED UNDERDOSE 1037 0.0519
245 SEROTONIN SYNDROME 998 0.0519
246 BREAST CANCER STAGE II 432 0.0519
247 NASOPHARYNGITIS 9499 0.0515
248 RENAL TUBULAR NECROSIS 502 0.0511
249 PROTHROMBIN TIME PROLONGED 306 0.0511
250 CONTUSION 4904 0.0509
251 NEUTROPHIL COUNT INCREASED 519 0.0506
252 APHTHOUS ULCER 393 0.0506
253 CONFUSIONAL STATE 8177 0.0505
254 TASTE DISORDER 1024 0.0504
255 INSURANCE ISSUE 771 0.0504
256 SLEEP DISORDER 3557 0.0503
257 HYPOXIA 1764 0.0500
258 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 389 0.0500
259 JOINT EFFUSION 345 0.0500
260 HYPERAMMONAEMIA 250 0.0499
261 CARDIO-RESPIRATORY ARREST 2088 0.0499
262 INFECTION 7214 0.0498
263 TREATMENT FAILURE 4117 0.0496
264 DRUG LEVEL INCREASED 822 0.0496
265 SKIN LACERATION 539 0.0495
266 BLOOD LACTIC ACID INCREASED 261 0.0495
267 PERIPHERAL SWELLING 7596 0.0493
268 TROPONIN INCREASED 375 0.0492
269 MUSCULOSKELETAL PAIN 2566 0.0489
270 LIVER DISORDER 2166 0.0488
271 ORAL CANDIDIASIS 643 0.0488
272 MYOSITIS 438 0.0488
273 CHRONIC KIDNEY DISEASE 3697 0.0486
274 ASPIRATION 532 0.0485
275 RHINITIS ALLERGIC 216 0.0485
276 SPUTUM DISCOLOURED 460 0.0485
277 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 825 0.0481
278 VASCULITIS 559 0.0479
279 APPENDICITIS 448 0.0479
280 TUBULOINTERSTITIAL NEPHRITIS 898 0.0479
281 HYPOTHERMIA 485 0.0479
282 THROAT IRRITATION 2142 0.0477
283 ABDOMINAL TENDERNESS 236 0.0475
284 ENCEPHALOPATHY 1167 0.0475
285 MYASTHENIA GRAVIS 383 0.0474
286 COMA 2255 0.0473
287 ACUTE KIDNEY INJURY 7246 0.0473
288 GANGRENE 284 0.0471
289 MEDICATION ERROR 2616 0.0470
290 SINUS CONGESTION 633 0.0468
291 SKIN INFECTION 524 0.0467
292 HYPERSENSITIVITY 8662 0.0466
293 BENIGN PROSTATIC HYPERPLASIA 240 0.0464
294 LEUKOCYTOSIS 841 0.0464
295 TRANSAMINASES INCREASED 1029 0.0462
296 DRUG LEVEL ABOVE THERAPEUTIC 211 0.0460
297 GENERALISED OEDEMA 567 0.0458
298 RESPIRATORY DISORDER 1367 0.0456
299 SKIN ABRASION 214 0.0452
300 GINGIVAL PAIN 360 0.0452
301 ALANINE AMINOTRANSFERASE INCREASED 2769 0.0451
302 CLOSTRIDIUM DIFFICILE COLITIS 478 0.0450
303 HAEMODYNAMIC INSTABILITY 343 0.0450
304 INTERNATIONAL NORMALISED RATIO INCREASED 1278 0.0448
305 CARDIOGENIC SHOCK 642 0.0447
306 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 264 0.0445
307 HEART RATE IRREGULAR 1007 0.0445
308 EXPOSURE DURING PREGNANCY 2766 0.0445
309 HYPOALBUMINAEMIA 346 0.0445
310 HEPATIC CIRRHOSIS 835 0.0444
311 ABDOMINAL DISCOMFORT 7447 0.0444
312 SENSORY LOSS 357 0.0443
313 ROAD TRAFFIC ACCIDENT 1844 0.0440
314 SINUS TACHYCARDIA 619 0.0435
315 JOINT STIFFNESS 1137 0.0433
316 NEUTROPENIC SEPSIS 309 0.0432
317 BACTERAEMIA 513 0.0432
318 BLOOD PRESSURE INCREASED 6586 0.0430
319 PYREXIA 14825 0.0428
320 HYPERBILIRUBINAEMIA 442 0.0426
321 HYPERTENSION 9021 0.0425
322 HAEMATOCRIT DECREASED 843 0.0425
323 CYSTITIS 1353 0.0424
324 MIOSIS 341 0.0424
325 ULCER 675 0.0424
326 ARTERIOSCLEROSIS CORONARY ARTERY 281 0.0424
327 ASPARTATE AMINOTRANSFERASE INCREASED 2227 0.0419
328 INTRACRANIAL PRESSURE INCREASED 233 0.0418
329 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2004 0.0417
330 TACHYCARDIA 3691 0.0415
331 HYPERTHERMIA 316 0.0414
332 COORDINATION ABNORMAL 577 0.0413
333 TENDERNESS 431 0.0413
334 DRY MOUTH 3354 0.0413
335 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1170 0.0413
336 OSTEOPOROSIS 1684 0.0409
337 ASPHYXIA 334 0.0409
338 SUBSTANCE ABUSE 333 0.0409
339 PERIORBITAL OEDEMA 212 0.0408
340 ACCIDENTAL OVERDOSE 1489 0.0407
341 PREGNANCY 813 0.0406
342 OVERDOSE 8754 0.0405
343 BRONCHITIS 3001 0.0405
344 BLOOD ALKALINE PHOSPHATASE INCREASED 1005 0.0404
345 BLOOD ALBUMIN DECREASED 320 0.0403
346 DERMATITIS CONTACT 458 0.0401
347 BLOOD TEST ABNORMAL 564 0.0401
348 FLANK PAIN 374 0.0399
349 EPILEPSY 1218 0.0398
350 PHARYNGITIS 493 0.0397
351 WEIGHT INCREASED 8899 0.0397
352 TOOTH ABSCESS 403 0.0395
353 TACHYPNOEA 538 0.0395
354 HYPOTENSION 7935 0.0395
355 TOOTH INFECTION 520 0.0394
356 THERAPY NON-RESPONDER 1773 0.0394
357 RASH MACULO-PAPULAR 877 0.0394
358 ALTERED STATE OF CONSCIOUSNESS 852 0.0393
359 RECTAL HAEMORRHAGE 1671 0.0389
360 POSTOPERATIVE WOUND INFECTION 261 0.0386
361 BLOOD BILIRUBIN INCREASED 1040 0.0385
362 HYPOVOLAEMIA 224 0.0382
363 ASCITES 1124 0.0382
364 BACTERIAL INFECTION 713 0.0382
365 HYPOGAMMAGLOBULINAEMIA 251 0.0382
366 FREQUENT BOWEL MOVEMENTS 1031 0.0381
367 ARTERIAL OCCLUSIVE DISEASE 298 0.0379
368 PHARYNGITIS STREPTOCOCCAL 408 0.0377
369 NEURALGIA 916 0.0376
370 UNRESPONSIVE TO STIMULI 962 0.0372
371 MIGRAINE 3555 0.0372
372 VENTRICULAR FIBRILLATION 413 0.0371
373 HYPOKALAEMIA 1708 0.0370
374 LOCALISED INFECTION 891 0.0368
375 BLOOD UREA INCREASED 616 0.0368
376 SCHIZOPHRENIA 447 0.0367
377 HYPONATRAEMIA 2070 0.0367
378 GAMMA-GLUTAMYLTRANSFERASE INCREASED 812 0.0366
379 INTENTIONAL SELF-INJURY 737 0.0365
380 HEAD DISCOMFORT 646 0.0365
381 ADVERSE REACTION 483 0.0364
382 NECK PAIN 2035 0.0364
383 PARAESTHESIA ORAL 524 0.0363
384 RENAL CYST 288 0.0362
385 PULMONARY MASS 540 0.0362
386 ARTHRITIS 2838 0.0360
387 HEPATOCELLULAR INJURY 511 0.0360
388 HEMIPLEGIA 299 0.0359
389 HAEMOLYSIS 277 0.0358
390 PNEUMONIA 11599 0.0358
391 STEVENS-JOHNSON SYNDROME 796 0.0358
392 GASTROOESOPHAGEAL REFLUX DISEASE 2876 0.0357
393 ABDOMINAL PAIN 8304 0.0357
394 URTICARIA 5976 0.0356
395 PYELONEPHRITIS 309 0.0356
396 COGNITIVE DISORDER 1659 0.0355
397 ARTHRALGIA 14754 0.0354
398 HAEMATEMESIS 898 0.0354
399 EYE INFECTION 400 0.0354
400 DYSPEPSIA 3484 0.0354
401 BLOOD CALCIUM INCREASED 310 0.0353
402 UPPER GASTROINTESTINAL HAEMORRHAGE 594 0.0353
403 HYPERAESTHESIA 290 0.0353
404 PRODUCTIVE COUGH 1683 0.0352
405 OCULAR DISCOMFORT 395 0.0351
406 LYMPHOEDEMA 243 0.0351
407 MOTOR DYSFUNCTION 358 0.0351
408 UROSEPSIS 324 0.0351
409 SINUS DISORDER 693 0.0350
410 PRESYNCOPE 849 0.0349
411 BLOOD CREATININE INCREASED 2277 0.0348
412 RESPIRATORY ARREST 960 0.0348
413 ANGIOEDEMA 1527 0.0345
414 OLIGURIA 214 0.0344
415 ALOPECIA 6746 0.0343
416 HYPOAESTHESIA 5141 0.0343
417 DUODENAL ULCER 242 0.0343
418 OROPHARYNGEAL DISCOMFORT 309 0.0342
419 POST-TRAUMATIC STRESS DISORDER 229 0.0341
420 SEPSIS 3803 0.0341
421 ACUTE RESPIRATORY FAILURE 655 0.0340
422 ACUTE RESPIRATORY DISTRESS SYNDROME 602 0.0340
423 ADRENAL INSUFFICIENCY 412 0.0339
424 RESPIRATORY SYNCYTIAL VIRUS INFECTION 295 0.0338
425 HEPATIC STEATOSIS 631 0.0338
426 PULMONARY CONGESTION 445 0.0337
427 PNEUMONIA ASPIRATION 843 0.0337
428 PURPURA 298 0.0336
429 CONDITION AGGRAVATED 10233 0.0336
430 HEART RATE INCREASED 3320 0.0335
431 CARDIOMEGALY 412 0.0335
432 PSEUDOMONAS INFECTION 287 0.0334
433 SPINAL OSTEOARTHRITIS 294 0.0334
434 MUSCULAR WEAKNESS 3795 0.0334
435 UPPER-AIRWAY COUGH SYNDROME 275 0.0333
436 HEPATOMEGALY 328 0.0333
437 ARTHROPOD BITE 247 0.0333
438 INTENTIONAL PRODUCT MISUSE 2917 0.0333
439 MENTAL STATUS CHANGES 924 0.0332
440 GASTROENTERITIS VIRAL 600 0.0332
441 ANAPHYLACTIC REACTION 1831 0.0331
442 PNEUMONIA BACTERIAL 303 0.0330
443 EOSINOPHIL COUNT INCREASED 275 0.0330
444 HYDRONEPHROSIS 247 0.0330
445 MOUTH ULCERATION 692 0.0328
446 PHOTOPHOBIA 617 0.0328
447 SARS-COV-2 TEST POSITIVE 433 0.0328
448 SPINAL DISORDER 310 0.0327
449 OEDEMA PERIPHERAL 3986 0.0327
450 GASTROINTESTINAL INFECTION 293 0.0327
451 CELLULITIS 1645 0.0326
452 JOINT INJURY 697 0.0326
453 TRICUSPID VALVE INCOMPETENCE 259 0.0326
454 AGRANULOCYTOSIS 604 0.0325
455 MUSCLE RIGIDITY 388 0.0324
456 VAGINAL DISCHARGE 326 0.0322
457 PRODUCT USE ISSUE 6055 0.0322
458 RESPIRATORY DISTRESS 889 0.0322
459 MYOCARDITIS 369 0.0322
460 TUMOUR LYSIS SYNDROME 283 0.0321
461 IRON DEFICIENCY ANAEMIA 295 0.0319
462 KIDNEY INFECTION 627 0.0319
463 VIRAL INFECTION 1063 0.0319
464 OBSTRUCTIVE AIRWAYS DISORDER 355 0.0319
465 LIVER FUNCTION TEST ABNORMAL 928 0.0319
466 ESCHERICHIA INFECTION 262 0.0318
467 NEPHROPATHY 297 0.0318
468 COVID-19 5578 0.0318
469 MALNUTRITION 355 0.0317
470 PANCREATITIS ACUTE 713 0.0317
471 WHITE BLOOD CELL COUNT INCREASED 1214 0.0316
472 CHOLELITHIASIS 1037 0.0316
473 PLEURAL EFFUSION 1924 0.0316
474 VOMITING 14854 0.0316
475 ABDOMINAL PAIN UPPER 6502 0.0315
476 POST PROCEDURAL INFECTION 256 0.0314
477 BRADYCARDIA 1667 0.0314
478 DRUG INTERACTION 4970 0.0313
479 LIGAMENT SPRAIN 309 0.0312
480 INTERVERTEBRAL DISC DEGENERATION 289 0.0312
481 RESPIRATORY TRACT CONGESTION 496 0.0312
482 SMALL INTESTINAL OBSTRUCTION 384 0.0312
483 URINARY TRACT INFECTION 5303 0.0311
484 LYMPHOPENIA 439 0.0310
485 MUSCULOSKELETAL CHEST PAIN 480 0.0310
486 ERYTHEMA MULTIFORME 289 0.0310
487 DECUBITUS ULCER 252 0.0309
488 GASTROENTERITIS 451 0.0309
489 OSTEOPENIA 467 0.0307
490 EOSINOPHILIA 539 0.0307
491 CHILLS 3604 0.0307
492 COLITIS 1161 0.0306
493 PAIN 18797 0.0306
494 OESOPHAGITIS 333 0.0304
495 ASTHMA 3443 0.0304
496 PRODUCT DISTRIBUTION ISSUE 282 0.0304
497 SEPTIC SHOCK 1321 0.0303
498 DRUG ABUSE 2527 0.0303
499 CONCUSSION 235 0.0303
500 PAROSMIA 229 0.0303
501 AFFECT LABILITY 292 0.0303
502 SINUS BRADYCARDIA 293 0.0303
503 THROMBOCYTOPENIA 3382 0.0302
504 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 5445 0.0302
505 INFLUENZA 3365 0.0301
506 EMPHYSEMA 304 0.0301
507 HYPOMAGNESAEMIA 419 0.0301
508 CANDIDA INFECTION 508 0.0301
509 NASAL CONGESTION 1765 0.0300
510 OROPHARYNGEAL PAIN 2776 0.0300
511 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 771 0.0299
512 RENAL INJURY 890 0.0299
513 SHOCK 689 0.0299
514 PULMONARY OEDEMA 1338 0.0298
515 DRUG LEVEL DECREASED 304 0.0298
516 DERMATITIS BULLOUS 216 0.0298
517 CHEST PAIN 5521 0.0298
518 APNOEA 232 0.0298
519 MYDRIASIS 382 0.0297
520 RASH 12960 0.0297
521 JAUNDICE 799 0.0297
522 GOUT 532 0.0296
523 SUBARACHNOID HAEMORRHAGE 302 0.0296
524 ATRIAL FLUTTER 236 0.0295
525 VITAMIN D DEFICIENCY 288 0.0295
526 PALLOR 803 0.0295
527 SLEEP APNOEA SYNDROME 562 0.0294
528 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2094 0.0294
529 RIB FRACTURE 605 0.0294
530 HAEMOGLOBIN DECREASED 3019 0.0294
531 BLOOD LACTATE DEHYDROGENASE INCREASED 464 0.0293
532 ANAL INCONTINENCE 263 0.0292
533 BLOOD MAGNESIUM DECREASED 252 0.0292
534 HYPERKALAEMIA 1023 0.0291
535 HEMIPARESIS 493 0.0291
536 RED BLOOD CELL COUNT DECREASED 832 0.0291
537 ABSCESS 464 0.0291
538 NODULE 379 0.0290
539 PHARYNGEAL SWELLING 284 0.0290
540 FACE OEDEMA 489 0.0290
541 COUGH 8129 0.0290
542 ECONOMIC PROBLEM 438 0.0289
543 DISABILITY 570 0.0288
544 SOMNOLENCE 5803 0.0288
545 URINE OUTPUT DECREASED 251 0.0287
546 BLOOD URINE PRESENT 545 0.0287
547 HYPERLIPIDAEMIA 343 0.0287
548 SWOLLEN TONGUE 896 0.0287
549 RENAL FAILURE 3807 0.0286
550 TOOTH FRACTURE 316 0.0286
551 PNEUMONITIS 778 0.0285
552 SHOCK HAEMORRHAGIC 232 0.0285
553 INTENTIONAL DRUG MISUSE 595 0.0284
554 NEPHROLITHIASIS 1304 0.0284
555 CLOSTRIDIUM DIFFICILE INFECTION 620 0.0284
556 DIVERTICULITIS 787 0.0284
557 HERPES ZOSTER 1625 0.0283
558 BLOOD PRESSURE DECREASED 1879 0.0283
559 NEPHROPATHY TOXIC 315 0.0280
560 RHINORRHOEA 1811 0.0280
561 FACIAL PAIN 250 0.0280
562 MUCOSAL INFLAMMATION 733 0.0280
563 NERVE COMPRESSION 258 0.0279
564 HEADACHE 17518 0.0279
565 FLUID RETENTION 1420 0.0279
566 RENAL FAILURE ACUTE 1182 0.0278
567 ARTERIOSCLEROSIS 262 0.0278
568 AMNESIA 1810 0.0278
569 WEIGHT DECREASED 7766 0.0278
570 CARDIAC ARREST 2296 0.0278
571 FOOT FRACTURE 527 0.0278
572 GASTRIC ULCER 528 0.0278
573 TOOTHACHE 502 0.0277
574 HAEMOPTYSIS 773 0.0277
575 PETECHIAE 289 0.0277
576 FACIAL PARALYSIS 236 0.0277
577 HYPERCALCAEMIA 341 0.0276
578 PLATELET COUNT INCREASED 360 0.0276
579 HYPOGLYCAEMIA 1336 0.0275
580 MYOCLONUS 328 0.0275
581 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 282 0.0274
582 POOR QUALITY SLEEP 591 0.0274
583 FATIGUE 21344 0.0274
584 BLOOD IRON DECREASED 325 0.0274
585 BACK PAIN 6338 0.0273
586 DYSPNOEA 15385 0.0272
587 EATING DISORDER 578 0.0271
588 FISTULA 305 0.0271
589 MITRAL VALVE INCOMPETENCE 307 0.0271
590 COLITIS ULCERATIVE 1211 0.0271
591 HAEMATURIA 925 0.0270
592 OFF LABEL USE 23632 0.0270
593 RESPIRATORY FAILURE 1962 0.0269
594 HAEMATOMA 694 0.0268
595 ASTHENIA 10046 0.0267
596 RHABDOMYOLYSIS 1113 0.0267
597 TOOTH DISORDER 593 0.0266
598 SKIN ULCER 689 0.0266
599 DECREASED APPETITE 6179 0.0266
600 LIMB INJURY 722 0.0266
601 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 219 0.0265
602 PANCYTOPENIA 1484 0.0265
603 PAIN IN EXTREMITY 7805 0.0265
604 RASH ERYTHEMATOUS 1266 0.0265
605 MULTI-ORGAN FAILURE 457 0.0264
606 LACTIC ACIDOSIS 856 0.0264
607 ELECTROLYTE IMBALANCE 307 0.0264
608 HIATUS HERNIA 342 0.0264
609 DIPLOPIA 686 0.0264
610 FALL 8790 0.0264
611 MELAENA 581 0.0264
612 CYANOSIS 414 0.0263
613 ANAEMIA 5012 0.0263
614 NEUTROPHIL COUNT DECREASED 1071 0.0263
615 NEUROLEPTIC MALIGNANT SYNDROME 310 0.0261
616 DENTAL CARIES 289 0.0261
617 FEELING HOT 1600 0.0261
618 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1361 0.0261
619 PRURITUS 9998 0.0260
620 TOXIC SKIN ERUPTION 262 0.0260
621 ORAL HERPES 507 0.0259
622 LEUKOPENIA 1298 0.0259
623 SPINAL PAIN 304 0.0259
624 BLOOD SODIUM DECREASED 489 0.0259
625 CHOLECYSTITIS 309 0.0259
626 FEELING COLD 721 0.0259
627 CHEST DISCOMFORT 2652 0.0259
628 TRANSFUSION 271 0.0258
629 FOETAL EXPOSURE DURING PREGNANCY 2100 0.0258
630 CONSTIPATION 5630 0.0258
631 BALANCE DISORDER 2224 0.0257
632 WRIST FRACTURE 308 0.0257
633 BLADDER DISORDER 255 0.0257
634 ABDOMINAL DISTENSION 2672 0.0256
635 HAEMORRHOIDS 498 0.0255
636 HALLUCINATION, VISUAL 537 0.0254
637 ELECTROCARDIOGRAM QT PROLONGED 910 0.0253
638 DISSEMINATED INTRAVASCULAR COAGULATION 356 0.0253
639 NIGHTMARE 874 0.0252
640 CONJUNCTIVITIS 468 0.0252
641 BLOOD POTASSIUM INCREASED 408 0.0251
642 MICTURITION URGENCY 287 0.0251
643 HAEMATOCHEZIA 1386 0.0251
644 IMMUNOSUPPRESSION 221 0.0250
645 TINNITUS 1151 0.0250
646 FULL BLOOD COUNT ABNORMAL 264 0.0249
647 ANGINA PECTORIS 714 0.0249
648 LUNG INFILTRATION 220 0.0249
649 THROAT TIGHTNESS 671 0.0248
650 DYSPNOEA EXERTIONAL 934 0.0248
651 PULMONARY EMBOLISM 2356 0.0248
652 DEVICE RELATED INFECTION 381 0.0247
653 SNEEZING 553 0.0246
654 HYPERHIDROSIS 3175 0.0246
655 PULMONARY HYPERTENSION 513 0.0246
656 TEMPERATURE INTOLERANCE 254 0.0246
657 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 418 0.0246
658 MALAISE 10783 0.0246
659 GLOMERULAR FILTRATION RATE DECREASED 302 0.0246
660 DYSARTHRIA 925 0.0245
661 CATARACT 1462 0.0245
662 GASTRITIS 645 0.0245
663 UVEITIS 332 0.0245
664 BACK DISORDER 397 0.0244
665 HERNIA 472 0.0244
666 INSOMNIA 6471 0.0243
667 PERIPHERAL COLDNESS 333 0.0242
668 BLOOD PRESSURE ABNORMAL 481 0.0242
669 DECREASED IMMUNE RESPONSIVENESS 237 0.0241
670 CYST 299 0.0241
671 DRUG ERUPTION 425 0.0240
672 EAR DISCOMFORT 246 0.0239
673 BASAL CELL CARCINOMA 373 0.0239
674 MUSCULOSKELETAL DISCOMFORT 410 0.0238
675 DIABETES MELLITUS INADEQUATE CONTROL 419 0.0236
676 PARAESTHESIA 3720 0.0236
677 NAUSEA 18640 0.0235
678 PAIN IN JAW 667 0.0235
679 NEUTROPENIA 3191 0.0234
680 THERAPEUTIC RESPONSE SHORTENED 778 0.0234
681 PSYCHOTIC DISORDER 692 0.0234
682 HYPERGLYCAEMIA 853 0.0234
683 ATRIAL FIBRILLATION 2276 0.0233
684 STAPHYLOCOCCAL INFECTION 770 0.0233
685 SPLENOMEGALY 273 0.0233
686 PANCREATITIS 1231 0.0233
687 HOSPICE CARE 230 0.0233
688 PNEUMOTHORAX 368 0.0232
689 MASS 324 0.0232
690 URINARY RETENTION 773 0.0231
691 PERICARDIAL EFFUSION 535 0.0231
692 HYPOTONIA 230 0.0230
693 PRODUCT USE IN UNAPPROVED INDICATION 5700 0.0230
694 HYPOCALCAEMIA 435 0.0230
695 SUPRAVENTRICULAR TACHYCARDIA 220 0.0230
696 FUNGAL INFECTION 765 0.0229
697 BRONCHOSPASM 327 0.0229
698 AGITATION 1679 0.0228
699 VENTRICULAR TACHYCARDIA 377 0.0228
700 DYSPHAGIA 2162 0.0228
701 LETHARGY 1310 0.0227
702 SYNCOPE 2270 0.0227
703 DEHYDRATION 3012 0.0226
704 APHASIA 681 0.0225
705 GAIT DISTURBANCE 4309 0.0225
706 EJECTION FRACTION DECREASED 348 0.0224
707 ILEUS 277 0.0223
708 RESTLESSNESS 813 0.0222
709 OSTEOMYELITIS 402 0.0222
710 MEMORY IMPAIRMENT 3030 0.0220
711 INTERVERTEBRAL DISC PROTRUSION 482 0.0220
712 PROTEINURIA 419 0.0220
713 PLATELET COUNT DECREASED 2348 0.0220
714 DIZZINESS POSTURAL 213 0.0219
715 INJECTION SITE EXTRAVASATION 271 0.0219
716 PRODUCT ADMINISTRATION ERROR 442 0.0218
717 DIARRHOEA 14058 0.0218
718 SKIN LESION 596 0.0217
719 LYMPHADENOPATHY 766 0.0216
720 VERTIGO 1309 0.0215
721 DEEP VEIN THROMBOSIS 1395 0.0214
722 POST PROCEDURAL COMPLICATION 412 0.0214
723 MUSCLE TWITCHING 494 0.0214
724 ILLNESS 2196 0.0213
725 ANAPHYLACTIC SHOCK 547 0.0212
726 DEPRESSION 4817 0.0212
727 SWELLING FACE 1375 0.0211
728 IMPAIRED QUALITY OF LIFE 303 0.0211
729 DRY THROAT 214 0.0210
730 RESTLESS LEGS SYNDROME 382 0.0210
731 ADVERSE DRUG REACTION 1886 0.0210
732 SUDDEN DEATH 222 0.0210
733 BLOOD CREATINE PHOSPHOKINASE INCREASED 601 0.0209
734 ANXIETY 5941 0.0209
735 URINARY INCONTINENCE 618 0.0208
736 ANHEDONIA 548 0.0208
737 EYE PAIN 1169 0.0207
738 CARDIOMYOPATHY 305 0.0206
739 ROTATOR CUFF SYNDROME 265 0.0206
740 DIZZINESS 10292 0.0206
741 MUSCLE SPASMS 3786 0.0206
742 INCONTINENCE 218 0.0206
743 SKIN HAEMORRHAGE 305 0.0206
744 MYOCARDIAL ISCHAEMIA 234 0.0205
745 SKIN REACTION 289 0.0205
746 ERYTHEMA 4195 0.0204
747 HYPOPHAGIA 519 0.0203
748 GALLBLADDER DISORDER 362 0.0203
749 FAECES DISCOLOURED 439 0.0202
750 DYSPHONIA 1184 0.0202
751 DYSURIA 745 0.0202
752 HYPOKINESIA 293 0.0202
753 ATAXIA 239 0.0201
754 DISORIENTATION 795 0.0200
755 RASH PRURITIC 1087 0.0200
756 ACCIDENT 239 0.0200
757 GLAUCOMA 385 0.0200
758 TENDONITIS 308 0.0199
759 DECREASED ACTIVITY 214 0.0198
760 LIP SWELLING 660 0.0198
761 INTERSTITIAL LUNG DISEASE 958 0.0198
762 BLOOD POTASSIUM DECREASED 594 0.0197
763 APHONIA 275 0.0197
764 INCORRECT PRODUCT ADMINISTRATION DURATION 426 0.0196
765 BRAIN FOG 308 0.0196
766 EPISTAXIS 1469 0.0196
767 WHITE BLOOD CELL COUNT DECREASED 2127 0.0196
768 FLUSHING 1983 0.0195
769 DEPRESSED MOOD 1030 0.0195
770 SECRETION DISCHARGE 244 0.0195
771 HALLUCINATION 1464 0.0194
772 SCAR 332 0.0194
773 HIP FRACTURE 622 0.0193
774 ANKLE FRACTURE 299 0.0193
775 SUBDURAL HAEMATOMA 276 0.0193
776 CARPAL TUNNEL SYNDROME 270 0.0193
777 LIMB DISCOMFORT 594 0.0192
778 INFLUENZA LIKE ILLNESS 1578 0.0192
779 GENERALISED TONIC-CLONIC SEIZURE 316 0.0191
780 HEAD INJURY 602 0.0190
781 HYPOTHYROIDISM 607 0.0190
782 NEUROPATHY PERIPHERAL 1805 0.0190
783 INTESTINAL PERFORATION 213 0.0190
784 THERAPY PARTIAL RESPONDER 296 0.0190
785 ISCHAEMIC STROKE 338 0.0189
786 RENAL IMPAIRMENT 1582 0.0188
787 PALPITATIONS 2202 0.0188
788 CIRCULATORY COLLAPSE 319 0.0187
789 ORAL PAIN 419 0.0187
790 FEEDING DISORDER 378 0.0186
791 ADVERSE EVENT 1717 0.0186
792 SPINAL FRACTURE 373 0.0186
793 PROCEDURAL PAIN 516 0.0186
794 HEPATIC FUNCTION ABNORMAL 692 0.0185
795 BEDRIDDEN 243 0.0185
796 EYE DISORDER 606 0.0184
797 CYTOMEGALOVIRUS INFECTION 306 0.0184
798 EYELID OEDEMA 214 0.0184
799 CORONARY ARTERY DISEASE 554 0.0183
800 IMPAIRED WORK ABILITY 391 0.0183
801 PHOTOSENSITIVITY REACTION 296 0.0179
802 IMPAIRED GASTRIC EMPTYING 244 0.0179
803 HYPERSOMNIA 513 0.0179
804 DEVICE OCCLUSION 251 0.0178
805 ACUTE MYOCARDIAL INFARCTION 525 0.0178
806 INTESTINAL OBSTRUCTION 671 0.0178
807 LABORATORY TEST ABNORMAL 524 0.0177
808 HALLUCINATION, AUDITORY 280 0.0176
809 ARRHYTHMIA 834 0.0176
810 CHROMATURIA 396 0.0175
811 MYALGIA 2972 0.0175
812 BLINDNESS 709 0.0174
813 CHOKING 339 0.0174
814 GASTROINTESTINAL HAEMORRHAGE 1452 0.0174
815 UNDERDOSE 1266 0.0173
816 CARDIAC FAILURE 1383 0.0172
817 GINGIVAL BLEEDING 234 0.0171
818 BONE DISORDER 312 0.0171
819 METASTASES TO BONE 280 0.0170
820 DYSSTASIA 498 0.0170
821 PREMATURE BABY 512 0.0170
822 DELUSION 264 0.0170
823 TREMOR 2817 0.0170
824 COLD SWEAT 299 0.0169
825 LOSS OF CONSCIOUSNESS 2168 0.0169
826 PULMONARY ARTERIAL HYPERTENSION 245 0.0169
827 SKIN DISORDER 562 0.0168
828 THROMBOSIS 1354 0.0168
829 THERAPEUTIC RESPONSE DECREASED 1020 0.0168
830 DERMATITIS ALLERGIC 211 0.0168
831 THYROID DISORDER 258 0.0167
832 METASTASES TO CENTRAL NERVOUS SYSTEM 215 0.0167
833 BONE DENSITY DECREASED 522 0.0166
834 TRANSIENT ISCHAEMIC ATTACK 562 0.0166
835 MOVEMENT DISORDER 532 0.0166
836 HOT FLUSH 1246 0.0165
837 ABDOMINAL PAIN LOWER 417 0.0165
838 UPPER LIMB FRACTURE 328 0.0164
839 FLUID OVERLOAD 238 0.0163
840 RASH PAPULAR 366 0.0163
841 SEIZURE 1878 0.0162
842 DEMENTIA 453 0.0162
843 HYPOAESTHESIA ORAL 244 0.0162
844 HAEMORRHAGE INTRACRANIAL 241 0.0161
845 TOOTH LOSS 334 0.0161
846 FEMUR FRACTURE 498 0.0161
847 RETCHING 339 0.0159
848 HYPERTHYROIDISM 230 0.0159
849 BONE PAIN 928 0.0158
850 RASH MACULAR 549 0.0157
851 DIABETES MELLITUS 1195 0.0157
852 MUSCULOSKELETAL DISORDER 298 0.0156
853 VISUAL IMPAIRMENT 1937 0.0156
854 PARALYSIS 223 0.0156
855 MUSCLE TIGHTNESS 251 0.0155
856 SENSORY DISTURBANCE 247 0.0154
857 LACRIMATION INCREASED 464 0.0153
858 LUNG INFECTION 237 0.0152
859 PARANOIA 262 0.0152
860 DISEASE PROGRESSION 1798 0.0152
861 ECZEMA 789 0.0151
862 DISTURBANCE IN ATTENTION 811 0.0150
863 TREATMENT NONCOMPLIANCE 821 0.0150
864 DRY EYE 748 0.0150
865 RENAL DISORDER 696 0.0149
866 SPEECH DISORDER 778 0.0148
867 PREMATURE DELIVERY 235 0.0147
868 DYSKINESIA 591 0.0145
869 PSYCHOMOTOR HYPERACTIVITY 241 0.0145
870 POLLAKIURIA 603 0.0144
871 DRUG INEFFECTIVE 18994 0.0144
872 SKIN DISCOLOURATION 661 0.0144
873 NEUROTOXICITY 252 0.0144
874 CEREBRAL HAEMORRHAGE 514 0.0143
875 PERITONITIS 295 0.0142
876 BONE MARROW FAILURE 286 0.0141
877 MULTIPLE FRACTURES 231 0.0140
878 ACUTE MYELOID LEUKAEMIA 219 0.0140
879 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 768 0.0140
880 FULL BLOOD COUNT DECREASED 282 0.0140
881 INTENTIONAL DOSE OMISSION 398 0.0139
882 EYE SWELLING 516 0.0139
883 LYMPHOMA 213 0.0138
884 THIRST 246 0.0138
885 BURNING SENSATION 961 0.0137
886 DEAFNESS 357 0.0136
887 VISION BLURRED 1862 0.0135
888 METASTASES TO LIVER 238 0.0135
889 PRODUCT DOSE OMISSION ISSUE 3957 0.0134
890 NERVOUS SYSTEM DISORDER 419 0.0134
891 MIDDLE INSOMNIA 249 0.0133
892 FEELING JITTERY 249 0.0131
893 DYSGEUSIA 966 0.0130
894 MENTAL DISORDER 563 0.0129
895 CARDIAC FAILURE CONGESTIVE 1035 0.0129
896 PRODUCT AVAILABILITY ISSUE 293 0.0129
897 PRODUCT PRESCRIBING ERROR 306 0.0128
898 INJECTION SITE REACTION 874 0.0127
899 HAEMORRHAGE 1326 0.0127
900 FLATULENCE 715 0.0126
901 SKIN CANCER 270 0.0125
902 SKIN FISSURES 245 0.0125
903 PLASMA CELL MYELOMA 489 0.0125
904 BLOOD TRIGLYCERIDES INCREASED 221 0.0125
905 SUICIDAL IDEATION 1136 0.0124
906 DISEASE RECURRENCE 590 0.0124
907 AGGRESSION 619 0.0124
908 FRACTURE 234 0.0123
909 PSORIASIS 1578 0.0121
910 CEREBROVASCULAR ACCIDENT 2030 0.0120
911 CARDIAC DISORDER 1111 0.0119
912 GASTRIC DISORDER 405 0.0118
913 MENTAL IMPAIRMENT 286 0.0118
914 FEAR 315 0.0117
915 CRYING 421 0.0116
916 PANIC ATTACK 421 0.0115
917 ABNORMAL BEHAVIOUR 453 0.0114
918 NERVOUSNESS 597 0.0114
919 MALIGNANT NEOPLASM PROGRESSION 1170 0.0114
920 NEOPLASM PROGRESSION 395 0.0113
921 INCREASED APPETITE 217 0.0113
922 DYSTONIA 220 0.0113
923 CEREBRAL INFARCTION 275 0.0112
924 DEATH 9665 0.0112
925 CONVULSION 641 0.0112
926 FEELING ABNORMAL 2665 0.0111
927 OCULAR HYPERAEMIA 525 0.0111
928 CARDIOVASCULAR DISORDER 277 0.0109
929 OSTEONECROSIS 356 0.0108
930 EYE PRURITUS 363 0.0108
931 HOSPITALISATION 1618 0.0105
932 DERMATITIS 220 0.0105
933 DRUG EXPOSURE DURING PREGNANCY 352 0.0103
934 MULTIPLE SCLEROSIS 492 0.0103
935 SKIN EXFOLIATION 868 0.0103
936 EMOTIONAL DISTRESS 1234 0.0102
937 PRODUCT PRESCRIBING ISSUE 222 0.0102
938 PRODUCT DOSE OMISSION IN ERROR 288 0.0102
939 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 237 0.0102
940 DIABETIC KETOACIDOSIS 241 0.0100
941 HYPOACUSIS 429 0.0100
942 INCORRECT DOSE ADMINISTERED 2265 0.0099
943 AGEUSIA 241 0.0097
944 PAIN OF SKIN 260 0.0096
945 IRRITABILITY 566 0.0094
946 MYOCARDIAL INFARCTION 1639 0.0094
947 NEOPLASM MALIGNANT 624 0.0093
948 EXTRAPYRAMIDAL DISORDER 231 0.0093
949 OSTEONECROSIS OF JAW 225 0.0091
950 BLOOD GLUCOSE DECREASED 436 0.0091
951 UNEVALUABLE EVENT 685 0.0090
952 RASH GENERALISED 233 0.0090
953 NEEDLE ISSUE 261 0.0090
954 THERAPY INTERRUPTED 632 0.0088
955 MOOD SWINGS 278 0.0087
956 MOOD ALTERED 231 0.0085
957 ANGER 284 0.0084
958 LUNG NEOPLASM MALIGNANT 339 0.0082
959 ABORTION SPONTANEOUS 330 0.0082
960 EMOTIONAL DISORDER 248 0.0080
961 BLOOD GLUCOSE INCREASED 1488 0.0079
962 MULTIPLE SCLEROSIS RELAPSE 541 0.0079
963 WITHDRAWAL SYNDROME 325 0.0077
964 SURGERY 453 0.0077
965 EYE IRRITATION 443 0.0077
966 DRUG ADMINISTRATION ERROR 232 0.0076
967 ACNE 563 0.0074
968 DEVICE DISLOCATION 315 0.0072
969 DRY SKIN 954 0.0071
970 PRODUCT QUALITY ISSUE 948 0.0070
971 EXPIRED PRODUCT ADMINISTERED 227 0.0068
972 THERAPEUTIC RESPONSE UNEXPECTED 272 0.0061
973 VAGINAL HAEMORRHAGE 262 0.0060
974 THERAPY CESSATION 295 0.0057
975 DRUG DEPENDENCE 922 0.0057
976 INJECTION SITE ERYTHEMA 655 0.0053
977 INJECTION SITE SWELLING 393 0.0051
978 SKIN IRRITATION 223 0.0049
979 INJECTION SITE PRURITUS 316 0.0047
980 BREAST CANCER 420 0.0045
981 DRUG WITHDRAWAL SYNDROME 386 0.0044
982 NO ADVERSE EVENT 777 0.0043
983 DEVICE ISSUE 373 0.0042
984 DRUG EFFECT DECREASED 221 0.0041
985 INJECTION SITE BRUISING 312 0.0039
986 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 268 0.0038
987 INJECTION SITE PAIN 1143 0.0037
988 ACCIDENTAL EXPOSURE TO PRODUCT 365 0.0035
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 681 0.0034
990 INJECTION SITE HAEMORRHAGE 262 0.0033
991 SKIN BURNING SENSATION 230 0.0032
992 DEVICE MALFUNCTION 219 0.0031
993 PROSTATE CANCER 224 0.0028
994 DRUG DOSE OMISSION 333 0.0020